AMBEY — Ambey Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapValue Trap

Annual balance sheet for Ambey Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5.12	2.89	10.2	11.6	17.6
Net Total Accounts Receivable
Net Total Receivables	73.8	90.8	37.9	190	422
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	200	243	275	484	865
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	155	241	242	271	382
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	446	559	576	794	1,272
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	219	216	203	310	396
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	525	369	340	479	509
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	-78.6	191	236	315	764
Total Liabilities & Shareholders' Equity	446	559	576	794	1,272
Total Common Shares Outstanding